Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DELIVERABLE VOLUME
Deliverable Volume      
Astrazeneca Pharma India Ltd.
BSE Code 506820
ISIN Demat INE203A01020
Book Value 319.60
NSE Code ASTRAZEN
Dividend Yield % 0.35
Market Cap 225958.75
P/E 113.46
EPS 79.66
Face Value 2  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
26-Dec-2025 389 199 51.16
24-Dec-2025 51 40 78.43
23-Dec-2025 150 81 54.00
22-Dec-2025 67 54 80.60
19-Dec-2025 165 110 66.67
18-Dec-2025 235 156 66.38
17-Dec-2025 57 33 57.89
16-Dec-2025 88 54 61.36
15-Dec-2025 118 61 51.69
12-Dec-2025 103 40 38.83
11-Dec-2025 374 242 64.71
10-Dec-2025 108 67 62.04
09-Dec-2025 418 107 25.60
08-Dec-2025 155 76 49.03
05-Dec-2025 70 41 58.57
04-Dec-2025 187 97 51.87
03-Dec-2025 79 40 50.63
02-Dec-2025 518 366 70.66
01-Dec-2025 357 154 43.14
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.